44 2033180199
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Clinical Cardiology Journal

Sign up for email alert when new content gets added: Sign up

Operations in the internal carotid artery in patients with atrial fibrillation with using dabigatran etexilate

International Conference on Heart Congress, Vascular Biology and Surgeon’s Meeting

December 04-05, 2017 Dallas, USA

Alexandr Korotkikh

Regional clinical hospital & Far Eastern State Medical University Russian Federation

Posters & Accepted Abstracts: Clin Cardiol J

Abstract :

Objective: To evaluate the effectiveness of dabigatran etexilate in patients with atrial fibrillation who underwent operative treatment at the ICA. Materials and Methods: From Sept 1, 2015 to Dec 27, 2016, in the Department of Vascular Surgery and Cardiology was performed 694 operations on the ICA. Of these 94 (13,5%), surgery patients with atrial fibrillation. The average age of patients in the main group 68,5 �?�?�?± 8,5 years, the control group - 65,0 �?�?�?± 10,2 years. The comparison groups significantly differed in the following characteristics: postinfarction cardiosclerosis in the anamnesis of the main group 25,5%, control �?¢�?�?�?�? 15,0% (P-value �?¢�?�?�?�? 0,015); NYHA functional class I, main group 16,0%, control �?¢�?�?�?�? 31,0 % (P-value 0,002); NYHA functional class III, 18.1%, control 4.8% (P-value 0.00028); diabetes mellitus main group 28.7%, controls 18,2% (P-value 0,024). All patients with atrial fibrillation for 5-7 days before surgery, warfarin was canceled and dabigatran etexilate was administered at a dose of 150 mg 2 times a day. When optimal numbers of INRs were reached, surgery was performed. Operational criteria and the results were evaluated in the endpoint - �?¢�?�?�?�?stroke + lethality.�?¢�?�?�? Results and Discussion: Total completed 84 CEA and CAS 10. The average time of operations of the main group 44,5 �?�?�?± 17,1 min, control group - 40,7 �?�?�?± 9,5 min, P-value <0,05. The average time of occlusion of ICA at CEA in the main group was 13,7 �?�?�?± 6,1 min, in the control group 13,1 �?�?�?± 1,8 min, P-value> 0,05. In patients with atrial fibrillation surgery performed significantly longer, but the time of the main stage - clamping ICA, were not significantly different. Consequently, an increase in the time of surgery is associated with a longer hemostasis at the stage of allotment of the ICA and/or after removal of the clamps off the arteries. In the early postoperative period, extensive hematomas in the postoperative areas and sites of arterial puncture were not noted. Indicator �?¢�?�?�?�?stroke + lethality�?¢�?�?�? inobservation group was 0%. Conclusions: CEA and CAS in patients with atrial fibrillation receiving dabigatran etexilate are effective and safe. When performing CEA, additional time is required for more thorough hemostasis.

Google Scholar citation report
Citations : 16

Clinical Cardiology Journal received 16 citations as per Google Scholar report